Alan Pestronk

29.1k total citations · 4 hit papers
242 papers, 15.3k citations indexed

About

Alan Pestronk is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alan Pestronk has authored 242 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Neurology, 80 papers in Molecular Biology and 67 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alan Pestronk's work include Peripheral Neuropathies and Disorders (68 papers), Myasthenia Gravis and Thymoma (41 papers) and Muscle Physiology and Disorders (39 papers). Alan Pestronk is often cited by papers focused on Peripheral Neuropathies and Disorders (68 papers), Myasthenia Gravis and Thymoma (41 papers) and Muscle Physiology and Disorders (39 papers). Alan Pestronk collaborates with scholars based in United States, France and Netherlands. Alan Pestronk's co-authors include Daniel B. Drachman, Conrad C. Weihl, Craig M. Zaidman, Virginia Kimonis, Robert H. Baloh, John W. Griffin, Glenn Lopate, Robert N. Adams, Ing Kao and Klaus V. Toyka and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Alan Pestronk

239 papers receiving 14.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

2004 1.0k citations Alan Pestronk et al. profile →
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1990 509 citations Ralph W. Kuncl, Lora Clawson et al. Annals of Neurology profile →
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

2013 492 citations Timothy M. Miller, Alan Pestronk et al. profile →
224th ENMC International Workshop:

2017 356 citations Yves Allenbach, Andrew L. Mammen et al. Neuromuscular Disorders profile →

Peers

Countries citing papers authored by Alan Pestronk

Since Specialization

Citations

This map shows the geographic impact of Alan Pestronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Pestronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Pestronk more than expected).

Fields of papers citing papers by Alan Pestronk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Pestronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Pestronk. The network helps show where Alan Pestronk may publish in the future.

Co-authorship network of co-authors of Alan Pestronk

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Pestronk. A scholar is included among the top collaborators of Alan Pestronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Pestronk. Alan Pestronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seeding-competent TDP-43 persists in human patient and mouse muscle 2024 ·Science Translational Medicine ·Eileen M. Lynch, Sara K. Pittman, Jil Daw, Chiseko Ikenaga, Sheng Chen, Dhruva D. Dhavale, Meredith E. Jackrel, Yuna M. Ayala, Paul T. Kotzbauer, Cindy V. Ly, Alan Pestronk, Thomas E. Lloyd, Conrad C. Weihl	6
2	Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices 2021 ·Neurology Genetics ·Marie Wencel, Aziz Shaibani, Namita Goyal, Mazen M. Dimachkie, Jaya Trivedi, Nicholas E. Johnson, Laurie Gutmann, Matthew Wicklund, (unknown), Angela Genge, Miriam Freimer, Neelam Goyal, Alan Pestronk, Julaine Florence, Chafic Karam, Jeffrey Ralph, (unknown), (unknown), Steve Hopkins, Tahseen Mozaffar	5
3	Preliminary Results from a Phase 2 Study to Evaluate ACE-083, a Local Muscle Therapeutic, in Patients with Facioscapulohumeral Muscular Dystrophy (S38.001) 2018 ·Neurology ·Jeffrey Statland, Anthony A. Amato, Elena Bravver, Craig Campbell, Lauren Elman, Nicholas E. Johnson, Nanette C. Joyce, Chafic Karam, John T. Kissel, Lawrence Korngut, Erin O’Ferrall, Georgios Manousakis, Alan Pestronk, Perry B. Shieh, Rabi Tawil, (unknown), (unknown), Matthew L. Sherman, Chad Glasser, Kenneth M. Attie	4
4	224th ENMC International Workshop: breakdown → 2017 ·Neuromuscular Disorders ·Yves Allenbach, Andrew L. Mammen, Olivier Benvéniste, Werner Stenzel, Anthony A. Amato, (unknown), Jan De Bleecker, Ingrid de Groot, Marjolein Visser, Hans H. Goebel, B. Hervier, (unknown), David Hilton‐Jones, Janine A. Lamb, Ingrid E. Lundberg, Tahseen Mozaffar, Ichizo Nishino, Alan Pestronk, Ulrike Schara, (unknown)	356
5	Identification of a Novel Immune Mediated Cause for Small Fiber Neuropathy (P4.137) 2017 ·Neurology ·Todd Levine, David Saperstein, Alan Pestronk, Jack W. Kent	4
6	Phase 1 Safety and Pharmacokinetics of the Novel Enzyme Replacement Therapy neoGAA in Treatment-Naïve and Alglucosidase Alfa-Treated Late-Onset Pompe Disease Patients (S38.005) 2016 ·Neurology ·Jaya Trivedi, Ans van der Ploeg, Richard J. Barohn, Barry J. Byrne, Claude Desnuelle, Özlem Göker-Alpan, Shafeeq Ladha, Pascal Laforêt, Eugen Mengel, Alan Pestronk, Jean Pouget, Benedikt Schoser, Volker Straub, Philip Van Damme, John Vissing, Peter Young, Raheel Shafi, Kerry Culm-Merdek, (unknown), (unknown)	1
7	Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study 2016 ·Journal of Neuromuscular Diseases ·Zohar Argov, Yoseph Caraco, Heather Lau, Alan Pestronk, Perry B. Shieh, Alison Skrinar, Tony Koutsoukos, (unknown), (unknown), Emil Kakkis	32
8	The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002) 2014 ·Neurology ·Matthew Harms, Janet Cady, Erica Koval, Bruno A. Benítez, Craig M. Zaidman, Jennifer Jockel‐Balsarotti, Peggy Allred, Robert H. Baloh, John Ravits, Ericka Simpson, Stanley H. Appel, Alan Pestronk, Alison Goate, Timothy M. Miller, Carlos Cruchaga	1
9	Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa 2012 ·Molecular Genetics and Metabolism ·Ans T. van der Ploeg, Richard J. Barohn, Lisa Carlson, Joel Charrow, Paula R. Clemens, Robert J. Hopkin, Priya S. Kishnani, Pascal Laforêt, Claire Morgan, Sharon Nations, Alan Pestronk, Horacio Plotkin, Barry E. Rosenbloom, Katherine B. Sims, Elisa Tsao	85
10	Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy 2010 ·Neuromuscular Disorders ·Craig M. Zaidman, Anne M. Connolly, Elizabeth C. Malkus, Julaine Florence, Alan Pestronk	56
11	Inflammatory myopathies with mitochondrial pathology and protein aggregates 2008 ·Journal of the Neurological Sciences ·Peyker Temız, Conrad C. Weihl, Alan Pestronk	77
12	G.P.9.09 Immediate release oral pentoxifylline is poorly tolerated in Duchenne muscular dystrophy boys 2007 ·Neuromuscular Disorders ·Diana M. Escolar, Carolina Tesi Rocha, Paula R. Clemens, Susan T. Iannaccone, Alan Pestronk, Nancy L. Kuntz, Andrew Zimmerman, Erik Henricson, Adrienne Arrieta, (unknown), Bruce M. Markle, Anne M. Connolly	2
13	M.P.2.05 Late onset Pompe disease is associated with impaired pulmonary and muscle function and diminished health-related quality of life 2007 ·Neuromuscular Disorders ·(unknown), Kenneth M. Jaffe, John H. J. Wokke, Pascal Laforêt, Alan Pestronk, Diana M. Escolar, J. Mayhew, Julaine Florence, Alison Skrinar	1
14	Brachio‐cervical inflammatory myopathies: Clinical, immune, and myopathologic features 2006 ·Arthritis & Rheumatism ·Alan Pestronk, (unknown), Glenn Lopate, Muhammad Al‐Lozi	25
15	Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide 2002 ·Muscle & Nerve ·Alan Pestronk, Rati Choksi, Eric L. Logigian, Muhammad Al‐Lozi	36
16	Autoimmune Myasthenia Gravis 1993 ·Hospital Practice ·Glenn Lopate, Alan Pestronk	7
17	Immune-mediated neuropathies 1993 ·Current Opinion in Neurology ·Andrew J. Kornberg, Alan Pestronk	15
18	The First Neurology Book Written in English (1650) by Robert Pemell 1989 ·Archives of Neurology ·Alan Pestronk	3
19	Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis 1989 ·Annals of Neurology ·Alan Pestronk, Robert N. Adams, David R. Cornblath, Ralph W. Kuncl, (unknown), Lora Clawson	85
20	Motor nerve outgrowth: reduced capacity for sprouting in the terminals of longer axons 1988 ·Brain Research ·Alan Pestronk, Daniel B. Drachman	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact